Hair loss in women

Minerva Ginecologica

Volumn 61, Issue 5, 2009, Pages 445-452

  Tosti, A ^a   Piraccini, B M ^a   Sisti, A ^a   Duque Estrada, B ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Institute of Dermatology   (Brazil)

Author keywords

Alopecia; Biotin; Contraceptive agents; Postpartum period; Trichotillomania

Indexed keywords

CONTRACEPTIVE AGENT;

ALOPECIA; ALOPECIA AREATA; EMOTIONAL STRESS; FEMALE; HAIR GROWTH; HAIR LOSS; HUMAN; IRON DEFICIENCY; PUERPERIUM; REVIEW; TRICHOTILLOMANIA;

ALOPECIA; BIOTIN; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; FINASTERIDE; GONADAL STEROID HORMONES; HAIR FOLLICLE; HUMANS; IRON; MINOXIDIL; PREGNANCY; PREGNANCY COMPLICATIONS; PUERPERAL DISORDERS; STRESS, PSYCHOLOGICAL; SUBSTANCE WITHDRAWAL SYNDROME; TRICHOTILLOMANIA;

EID: 71949126744     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Hadshiew IM, Foitzik K, Arck PC, Paus R. Burden of hair loss: stress and the underestimated psychosocial impact of TE and androgenetic alopecia. J Invest Dermatol 2004;123:455-457 (Pubitemid 39095613)
2. Chartier MB, Hoss DM, Grant-Kels JM. Approach to the adult female patient with diffuse nonscarring alopecia. J Am Acad Dermatol 2002;47:809-818
3. Hordinsky MK. Medical treatment of noncicatricial alopecia. Semin Cutan Med Surg 2006;25:51-55
4. Lynfield YL. Effect of pregnancy on the human hair cycle. J Invest Dermatol 1960;83:175-198
5. Randall VA. The endocrine control of the hair follicle. In: Blume-Peytavi U, Tosti A, Whiting DA, Trüeb R, editors. Hair growth and disorders. Berlin: Springer; 2008. p. 23-36.
6. Nissimov J, Elchalal U. Scalp hair diameter increases during pregnancy. Clin Exp Dermatol 2003;28:525-530 (Pubitemid 37100558)
7. Headington JT. Telogen effluvium: new concepts and review. Arch Dermatol 1993;129:356-363 (Pubitemid 23077458)
8. Pringle T. The relationship between thyroxine, oestradiol, and postnatal alopecia with relevance to women's health in general. Med Hypotheses 2000;55:445-449
9. Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol 2006;54:824-844
10. Peters EMJ, Arck PC, Paus R. Hair growth inhibition by psychoemotional stress: a mouse model for neural mechanisms in hair growth control. Exp Dermatol 2006;15:1-13.
11. Arck PC, Handjiski B, Peters EM, Peter AS, Peter AS, Hagen E, Fischer A et al. Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathos 2003;162:803-814 (Pubitemid 36237489)
12. DA Whiting. Chronic telogen effluvium. Dermatol Clin 1996;14:723-731
13. Ellis JA, Scurrah KJ, Cobb JE, Zaloumis SG, Duncan AE, Harrap SB. Baldness and the androgen receptor: the AR polyglycine repeat polymorphism does not confer susceptibility to androgenetic alopecia. Hum Genet 2007;121:451-457
14. Birch MP, Lashen H, Agarwal S, Messenger AG. Female pattern hair loss, sebum excretion and the end-organ response to androgens. Br J Dermatol 2006;154:85-89 (Pubitemid 43381325)
15. [No authors listed]. Hair loss and contraceptives. Br Med J 1973 2;2:499-500.
16. Brache V, Faundes A, Alvarez F, Cochon L. Non-menstrual adverse events during use of implantable contraceptives for women: data from clinical trials. Contraception 2002;65:63-74. (Pubitemid 34175239)
17. Kauschansky A, Lurie R, Ingber A. Hair loss in children on long-acting gonadotropin-releasing hormone agonist triptorelin treatment. Acta Derm Venereol 1997;77:333. (Pubitemid 27286481)
18. Gateley CA, Bundred NJ. Alopecia and breast disease. BMJ 1997;15:314:481.
19. Simpson D, Curran MP, Perry CM. Letrozole: a review of its use in postmenopausal women with breast cancer. Drugs 2004;64:1213-1230 (Pubitemid 38858289)
20. Phillips E, Bauman C. Safety surveillance of esterified estrogens-methyltestosterone (Estratest and Estratest HS) replacement therapy in the United States. Clin Ther 1997;19:1070-1084 (Pubitemid 27508942)
21. Grevelman EG, Breed WP. Prevention of chemotherapy-induced hair loss by scalp cooling. Ann Oncol 2005;16:352-358
22. Duvic M, Lemak NA, Valero V, Hymes SR, Hymes SR, Farmer KL, Hortobagyi GN et al. A randomized trial of minoxidil in chemotherapy-induced alopecia. J Am Acad Dermatol 1996;35:74-78 (Pubitemid 26231327)
23. Kantor J, Kessier LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Inv Dermatol 2003;121:985-988 (Pubitemid 37430963)
24. Sinclair R. There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br J Dermatol 2002;147:982-984 (Pubitemid 35370025)
25. Goldsmith LA. Vitamins and alopecia. Arch Dermatol 1980;116:1134-1135
26. Nyhan WL. Inborn errors of biotin metabolism. Arch Dermatol 1987;123:1696a-8a.
27. Arslam M, Vurucu S, Balamtekin N, Unay B, Akin R, Ozcan O. The effects of biotin supplementation on serum and liver tissue biotinidase enzyme activity and alopecia in rats which were administrated to valproic acid. Brain Dev 2008;DOI:10.1016/j.brain-dev.2008.07.008.
28. Boccaletti V, Zendri E, Giordano G, Gnetti L, De Panfilis G.. Familial uncombable hair syndrome: ultrastructural hair study and response to biotin. Ped Dermatol 2007; E14-E16. DOI: 10.1111/j.1525-1470.2007.00385.x.
29. Shelley WB, Shelley D. Umcombable hair syndrome: observations on response to biotin and occurence in siblings with ectodermal dysplasia. J Am Acad Dermatol 1985;13:97-102.
30. Mock DM, Quirk JG, Mock NI. Marginal biotin deficiency during normal pregnancy. Am J Clin Nutr 2002;75:295-299
31. Shrivastava SB. Diffuse hair loss in an adult female: Approach to diagnosis and management. Indian J Dermatol Venereol Leprol 2009;75:20-28
32. Feidler VC, Hafeez A. Diffuse alopecia: telogen hair loss. In: Olsen EA, editor. Disorders of hair growth. Diagnosis and treatment. 2nd ed. New York, NY: McGraw-Hill; 2003. p. 301-321
33. Tosti A, Camacho-Martinez F, Dawber R. Management of androgenetic alopecia. J Eur Acad Dermatol Venereol 1999;12:205-214
34. Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol 2004;50:541-553 (Pubitemid 38393163)
35. Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2002;47:377-385
36. Finasteride Male Pattern Hair Loss Study Group. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol 2002;12:38-49.
37. MacDonald Hull SP, Wood ML, Hutchinson PE, Sladden M, Messenger AG; British Association of Dermatologists. British Association of Dermatologists, Guidelines for the management of alopecia areata. Br J Dermatol 2003;149:692-699
38. Kurosawa M, Nakagawa S, Mizuashi M, Sasaki Y, Kawamura M, Saito M et al. A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata. Dermatology 2006;212:361-365
39. Tosti A, Piraccini BM, Pazzaglia M, Vincenzi C. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. J Am Acad Dermatol 2003;49:96-98 (Pubitemid 36801639)
40. Tosti A, Bellavista S, Iorizzo M. Alopecia areata: a long term follow-up study of 191 patients. J Am Acad Dermatol 2006;55:438-441 (Pubitemid 44189598)
41. Sehgal VN, Srivastava G. Trichotillomania ± trichobezoar: revisited. J Eur Acad Dermatol Venereol 2006;20:911-995